Cannabis & psychoses
Scientific information, risks and early detection
General information
Psychotic symptoms or psychotic episodes can take very different forms. Typical features are changes in perception, thinking or sense of reality, which can be deeply unsettling for those affected and the people around them. Psychoses are not a single disease but an umbrella term for various disorders with many possible causes. These include genetic and biological factors, neurodevelopmental conditions, stressful life events, ongoing stress, physical illness — and, in some people, the use of psychoactive substances.
Cannabis can amplify or trigger psychotic symptoms in some individuals. How strong this effect is, however, depends on many individual factors. People react very differently. While the majority of people who use cannabis never experience psychotic symptoms, there are groups who are more sensitive.
Groups at heightened risk
Adolescents and young adults,
because key brain regions continue to develop until around the mid-twenties.
People with family or genetic predisposition,
for example with mental illness in close relatives.
People with stressful life events or chronic stress,
who are already under psychological strain.
People with very frequent or high-THC use,
especially over many years.
Recognising early warning signs
Psychotic developments rarely come out of the blue. Changes often emerge gradually — for example through withdrawal, mood swings, difficulty concentrating, unusual perceptions, or a changed way of coping with stress. Taking such subtle warning signs seriously and offering support early is a key part of prevention.
Current state of research
Research on cannabis and psychotic disorders is extensive but is being further intensified, as many questions remain unresolved. There is agreement that the interaction of various factors is decisive. Only a small proportion of people who use cannabis develop psychotic symptoms.
More recent international studies from regulated markets such as Canada, Uruguay and individual US states show a mixed picture. Some studies report more diagnosed psychoses, while others show stable numbers without a measurable increase.
Possible reasons include
Changes in diagnosis and help-seeking behaviour,
because the threshold for seeking support drops after regulation.
Methodological limitations of the studies,
for example missing control groups or insufficient data on individual risk profiles.
Differing THC content and consumption patterns,
which vary strongly by region.
Social changes,
which occur independently of regulation and can influence diagnoses.
A central finding of several reviews is this: it is not regulation itself that leads to increased risk, but rather specific risk constellations interacting with consumption patterns. At the same time, public-health research shows that regulation offers important opportunities that do not exist in the illegal market.
Regulated markets enable, for example
- Age verification that makes early use harder.
- Transparent THC content, so risky products can be identified and avoided.
- Lower-risk products with a balanced THC–CBD ratio.
- Qualified counselling at official points of sale.
- Preventive information services that reach people who use cannabis before problems arise.
- Early detection and early intervention, via trained professionals.
- De-stigmatisation, so people affected raise psychological strain earlier and seek help.
For the first time, these conditions create structures that enable systematic prevention and early intervention.
Own project
Early detection and early intervention
Swiss Cannabis Research aims to actively help reduce the risk of psychotic developments in the context of cannabis use. Research shows that timely support and short paths to counselling or treatment are decisive for how a mental-health crisis unfolds. We therefore focus specifically on early detection.
In collaboration with specialists from medicine, psychiatry and prevention, we are developing a cannabis-specific early-detection tool intended to help assess individual risk more accurately. The aim is to capture changes in thinking, perception or behaviour early, before symptoms become entrenched.
The tool aims to
- Systematically capture relevant risk factors without stigmatising.
- Recognise early warning signs of psychotic developments and classify them accessibly.
- Be accessible anonymously and low-threshold, especially for young people.
- Offer orientation without making diagnoses or pathologising.
- Concrete recommendations for suitable counselling or support services.
- Strengthening self-reflection and raising awareness of mental health.
The overarching goal is to recognise mental-health crises as early as possible and take timely counter-measures. Young people and young adults in particular are to be protected through this approach, as they statistically represent the most vulnerable group and are at the same time the hardest to reach via traditional counselling channels.
Swiss Cannabis Research pursues a prevention approach based on scientific evidence and practical experience. The focus is on support, education and agency — not moralising or scare tactics. Responsible regulation, for the first time, makes it possible to address risks specifically and to systematically prevent psychotic developments.
Talking with young people about cannabis and mental health
Within our school prevention services, we address cannabis-induced psychotic symptoms directly — not to create fear, but to foster understanding and help people put risks into context. Young people experience many changes in thinking, feeling and behaviour as they grow up. These can be part of normal development, but sometimes they may also be signs of overload or psychological strain. That is precisely why it is important that young people learn to notice such changes and take them seriously, rather than dismissing them or keeping them to themselves.
Our approach relies on knowledge and self-reflection. We explain in accessible terms why a young brain reacts more sensitively to cannabis, what role THC content, patterns of use and stress play, and why some people are particularly vulnerable. At the same time, we show that psychotic symptoms do not just “happen”, but are often recognisable early on. By learning to recognise warning signs in their own behaviour or among friends, young people are strengthened in their ability to act.
In our workshops, these contents are not taught theoretically, but through examples, anonymised case stories and interactive exercises. Young people get the chance to ask questions, classify their own observations and critically question myths. This creates an open dialogue that reduces fear and broadens knowledge about mental health.
Our messages to schools are
Psychological changes are common — and it's important to talk about them.
Not every use leads to psychoses, but some situations clearly increase the risk.
People who recognise warning signs can get help early — for themselves or others.
Asking for help is not a sign of weakness, but of responsibility.
Through this integrative approach, our school programmes help link risk knowledge about cannabis with a broader strengthening of mental-health literacy. Young people should learn not only to know the risks but also to build protective factors — such as stress-coping skills, conscious handling of peer pressure, stable relationships, and seeking support early.
Combined with our planned early-detection tool, this creates a comprehensive approach that connects research, prevention and practice. Prevention happens not only through prohibitions and warnings but through knowledge, dialogue, reflection and concrete options for action.